trial

Transcranial Direct Current Stimulation (tDCS) for Treatment of Negative Syndrome in Patients With Schizophrenia

NCTId NCT01378078
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Completed
Enrollment 20 (actual)
Sponsored by Ludwig-Maximilians - University of Munich
Primary completion 2013-06
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Completed
Enrollment
20 (actual)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Double
Start
2011-06
Primary completion
2013-06
Eligibility
ALL · 18 Years · 65 Years

Interventions & indications

Drugs
eldith DC-stimulator (neuroconn, Ilmenau, Germany)

Sponsors

Ludwig-Maximilians - University of MunichLead Sponsor

Investigators

1
Ulrich Palm, MDPrincipal Investigator

Sites

1 total
Munich, Germany

Facts & assertions

4 sourced
Enrollment
20
Phase
NA
Primary Completion Date
2013-06
Status
COMPLETED
relationships
The graph out of here
drug
eldith DC-stimulator (neuroconn, Ilmenau, Germany)
drug
lead_sponsor
Ludwig-Maximilians - University of Munich
company
indication
Schizophrenia
indication
Schizophrenia
indication
investigator
Ulrich Palm, MD
person